Clinical Trials

Showing trials with last updates posted in 2025.

NCT05365035 | RECRUITING | PHASE2
60 participants

A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-31
Start Date:
2022-09-23
Completion:
2027-12-31
Conditions
  • Myelodysplastic Syndromes
  • Myeloproliferative Chronic Myelomonocytic Leukemia
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page